Peter R Flatt Selected Research

glycated insulin

5/2003	Meal-induced 24-hour profile of circulating glycated insulin in type 2 diabetic subjects measured by a novel radioimmunoassay.
2/2003	Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter R Flatt Research Topics

Disease

96	Body Weight (Weight, Body) 02/2024 - 09/2004
87	Type 2 Diabetes Mellitus (MODY) 02/2024 - 02/2002
81	Insulin Resistance 02/2024 - 06/2003
74	Obesity 02/2024 - 04/2002
12	Glucose Intolerance 04/2024 - 02/2006
5	Weight Loss (Weight Reduction) 04/2023 - 10/2017
4	Diabetes Mellitus 01/2024 - 11/2002
3	Hyperglycemia 05/2023 - 06/2011
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020 - 02/2004
3	Weight Gain 01/2020 - 12/2006
3	Bone Resorption 10/2016 - 10/2013
3	Necrosis 10/2011 - 11/2005
2	Hyperplasia 01/2023 - 08/2005
2	Polydipsia 11/2016 - 10/2016
2	Hyperphagia (Overeating) 11/2016 - 02/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 10/2015
2	Cognitive Dysfunction 11/2015 - 09/2010
2	Inflammation (Inflammations) 11/2014 - 11/2014
2	Neoplasms (Cancer) 07/2014 - 05/2008
2	Tetraploidy 02/2013 - 06/2011
2	Osteoporosis 09/2010 - 05/2008
2	Hypertrophy 12/2007 - 08/2005
1	Bone Fractures (Bone Fracture) 01/2024
1	Cysts 09/2023

Drug/Important Bio-Agent (IBA)

108	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 02/2002
81	Insulin (Novolin)FDA Link 02/2024 - 04/2002
66	Peptides (Polypeptides)IBA 02/2024 - 11/2002
38	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2024 - 01/2004
25	Glucagon (Glukagon)FDA Link 06/2023 - 12/2003
18	IncretinsIBA 01/2024 - 12/2003
17	Blood Glucose (Blood Sugar)IBA 02/2024 - 09/2006
15	gastric inhibitory polypeptide receptorIBA 04/2023 - 02/2002
15	Hormones (Hormone)IBA 01/2018 - 10/2003
13	Exenatide (Byetta)FDA Link 04/2024 - 02/2009
13	EnzymesIBA 01/2023 - 02/2002
12	Hypoglycemic Agents (Hypoglycemics)IBA 05/2023 - 01/2004
12	Triglycerides (Triacylglycerol)IBA 10/2020 - 12/2007
10	Streptozocin (Streptozotocin)FDA Link 08/2021 - 06/2011
10	xenin 25 (xenin)IBA 01/2021 - 08/2012
9	LipidsIBA 02/2024 - 10/2015
9	Liraglutide FDA Link 04/2023 - 08/2010
8	Pro(3)- glucose-dependent insulinotropic polypeptideIBA 07/2012 - 02/2002
6	OxyntomodulinIBA 01/2016 - 12/2010
5	Antimicrobial Cationic PeptidesIBA 02/2024 - 07/2014
5	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 08/2010
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 09/2005
5	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 10/2013 - 09/2005
4	Alanine (L-Alanine)FDA Link 04/2024 - 11/2005
4	Glucagon-Like Peptide-1 ReceptorIBA 04/2023 - 04/2007
4	Amylases FDA Link 01/2023 - 07/2016
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 09/2006
4	AmidesIBA 12/2020 - 01/2018
4	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020 - 06/2007
4	Cholecystokinin (Pancreozymin)IBA 01/2018 - 08/2013
4	monomethoxypolyethylene glycol (MPEG)IBA 08/2013 - 06/2008
3	tirzepatideIBA 02/2024 - 01/2022
3	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 10/2006
3	dapagliflozinIBA 12/2020 - 09/2017
3	CholesterolIBA 05/2020 - 04/2016
3	apelin-13 peptideIBA 01/2020 - 12/2017
3	ApelinIBA 01/2020 - 12/2017
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 01/2014
3	(pGlu-Gln)-CCK-8IBA 08/2015 - 01/2013
3	PalmitatesIBA 08/2012 - 11/2002
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 05/2008 - 10/2006
2	peptide-Gly-Leu-amideIBA 02/2024 - 01/2021
2	Peptide Hormones (Polypeptide Hormones)IBA 01/2024 - 01/2018
2	semaglutideIBA 04/2023 - 01/2022
2	4-(3-3,4-p-menthadien-(1,8)-yl)olivetolIBA 01/2023 - 12/2016
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2023 - 08/2022
2	Peptide YYIBA 01/2021 - 01/2018
2	CeruletideIBA 01/2021 - 06/2011
2	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2021 - 01/2013
2	HDL CholesterolIBA 05/2020 - 01/2018
2	LDL CholesterolIBA 01/2018 - 01/2013
2	esculentin steroidIBA 10/2017 - 01/2015
2	Insulin SecretagoguesIBA 04/2016 - 01/2004
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2015 - 02/2010
2	SecretagoguesIBA 10/2015 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 07/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2013 - 06/2011
2	CytokinesIBA 10/2011 - 11/2005
2	Arginine (L-Arginine)FDA Link 10/2011 - 11/2005
2	AdiponectinIBA 02/2009 - 06/2008
2	AM 251 (AM251)IBA 06/2008 - 02/2008
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 06/2008 - 02/2008
2	CannabinoidsIBA 06/2008 - 02/2008
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2007 - 04/2006
2	glycated insulinIBA 05/2003 - 02/2003
1	Dopamine (Intropin)FDA LinkGeneric 04/2024
1	Levodopa (L Dopa)FDA LinkGeneric 04/2024
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Glucagon-Like Peptide-2 ReceptorIBA 01/2024
1	Capsules (Microcapsules)IBA 09/2023
1	Amino Acids FDA Link 05/2023

Therapy/Procedure

37	Therapeutics 02/2024 - 10/2003
11	Intraperitoneal Injections 04/2023 - 02/2006
5	Injections 01/2020 - 09/2005
3	Oral Administration 04/2023 - 07/2019
2	Glycemic Control 10/2017 - 01/2009